APA (7th ed.) Citation

Yuping Yang, Yuping Yang, Weinan Yuan, Kun He, Chuangzhen Lin, Chuangzhen Lin, . . . Biao Nie. (2024). Inhibition of ACOX1 enhances the therapeutic efficacy of obeticholic acid in treating non-alcoholic fatty liver disease and mitigates its lipotoxicity. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Yuping Yang, Yuping Yang, Weinan Yuan, Kun He, Chuangzhen Lin, Chuangzhen Lin, Shenshen Du, Yanqi Kou, and Biao Nie. Inhibition of ACOX1 Enhances the Therapeutic Efficacy of Obeticholic Acid in Treating Non-alcoholic Fatty Liver Disease and Mitigates Its Lipotoxicity. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Yuping Yang, et al. Inhibition of ACOX1 Enhances the Therapeutic Efficacy of Obeticholic Acid in Treating Non-alcoholic Fatty Liver Disease and Mitigates Its Lipotoxicity. Frontiers Media S.A., 2024.